БИОМЕДИЦИНСКИЙ ЖУРНАЛ МЕДЛАЙН.РУ
Содержание журнала

Архив

Редакция
Учредители

Федеральное государственное бюджетное учреждение науки
"Институт токсикологии Федерального медико-биологического агентства"


Федеральное государственное бюджетное учреждение науки
Институт теоретической и экспериментальной биофизики
Российской академии наук


ООО "ИЦ КОМКОН"

Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314
Фундаментальные исследования • Экспериментальная токсикология

Том: 21
Статья: « 63 »
Страницы:. 768-798
Опубликована в журнале: 21 мая 2020 г.

English version

Фаллоидиновый синдром: актуальные направления токсикокинетической и токсикодинамической терапии

Ховпачев А.А., Башарин В.А., Чепур С.В.

ФГБВОУ ВО «Военно-медицинская академия им. С.М. Кирова»
ФГБУ «Государственный научно-исследовательский испытательный институт
военной медицины» МО РФ


Резюме
Фаллоидиновый синдром представляет серьезную проблему вследствие частоты встречаемости, сложности диагностики и отсутствия эффективных средств специальной терапии и низкой выживаемости пациентов, в том числе после ургентной трансплантации печени. Прослежены особенности опосредованного аманитином токсического про-цесса и раскрыты взаимодействия всех групп токсинов в составе плодовых тел, которые могут играть большую роль в потенцировании токсичности аманитина, чем просто индукция гастроинтестинальных явлений. Рассмотрены преимущества и недостатки основных видов терапии, направленных на перераспределение аманитотоксинов в организме и их взаимодействие с основными рецепторами токсичности. Оценена роль средств, ингибирующих активность OATP1В3-переносчика и РНК-полимеразы II.


Ключевые слова
отравления, мицетизм, грибы, аманитин, полимиксин В, терапия.



(статья в формате PDF. Для просмотра необходим Adobe Acrobat Reader)



открыть статью в новом окне

Список литературы

1. Вишневский М.В. Ядовитые грибы России [Текст]. М: Проспект, 2019. 448 с.


2. Гуревич Л.С., Журкович И.К., Нездойминого Э.Л. Изучение токсинов Amanita verna (Bull.: Fr.) Vitt. и A. virosa (Bull.: Fr.) Vitt. методом высокоэффективной жидкост-ной хроматографии / Микология и фитопатология. 1995. Т. 29, 3. С. 32-39.


3. Зарафьянц Г.Н. Судебно-медицинская диагностика отравлений некоторыми ядо-витыми грибами при летальном исходе в стационаре / Судебно-медицинская эксперти-за. 2016. 1. С. 22-28. doi: 10.17116/sudmed201659122-28.


4. Медицинская токсикология: Национальное руководство [Текст]. Ред.: Е.А. Луж-ников. М.: ГЭОТАР-Медиа, 2012. 928 с.


5. Мусселиус С.Г., Рык. А.А. Отравления грибами [Текст]. М.: [б. и.], 2002. 310 с.


6. Нездойминого Э.Л. Семейство паутинниковые [Текст]. СПб.: Наука, 1996. 408 с. (Определитель грибов России: Порядок агариковые; Вып. 1).


7. Федеральные клинические рекомендации. Токсическое действие других ядови-тых веществ, содержащихся в съеденных грибах / Ред. Ю.Н. Остапенко. - М.: Ассоци-ация клинических токсикологов, 2014. 37 с. - Электронный ресурс // Русскоязычное токсикологическое общество [вебсайт]. 2020. URL: http://www.toxrus.ru/node/49. (Дата обращения: 10.03.2020).


8. Цоколов А.В., Ильин И.Б., Настаева М.В. и др. Повреждение сердца при остром отравлении аматоксином: электрокардиографические и морфологические составляю-щие / Тезисы VI Евразийского конгресса кардиологов. 2018. С. 47.


9. Шилов В.В., Мартинсон Т.Г., Лукин В.А. Острые отравления ядовитыми гриба-ми: пособие для врачей [Текст]. СПб.: издание Политех. Ин-та, 2010. 23 с.


10. Avedissian S.N., Liu J., Rhodes N.J. et al. A review of the clinical pharmacokinetics of Polymyxin B / Antibiot. (Basel). 2019. Vol. 8, 1. 12 р. doi: 10.3390/antibiotics8010031


11. Beuhler M.C. Overview of mushroom poisoning / Crit. Care Toxicol. 2016. P. 1-26. doi: 10.1007/978-3-319-20790-2_120-1.


12. Boyer J.C., Hernandez F., Estorc J. et al. Management of maternal Amanita phal-loides poisoning during the first trimester of pregnancy: a case report and review of the litera-ture / Clin. Chem. 2001. Vol. 47. P. 971-974. doi: 10.1093/clinchem/47.5.971.


13. Brandenburg W.E., Ward K.J. Mushroom poisoning epidemiology in the United States / Mycologia. 2018. Vol. 110, N 4. Р. 637-641. doi: 10.1080/00275514.2018.1479561.


14. Chang I.M. Liver-protective activities of aucubin derived from traditional oriental medicine / Res. Commun. Mol. Pathol. Pharmacol. 1998. Vol. 102, N 2. Р. 189-204.


15. Derheimer F. A., OHagan H. M., Krueger H. M. et al. RPA and ATR link transcrip-tional stress to p53 / Proceed. Nation. Acad. Sci. 2007. Vol. 104, N 31. Р. 12778-12783. doi: 10.1073/pnas.0705317104.


16. El-Gebali S., Mistry J., Bateman A. et al. The Pfam protein families database in 2019 / Nucleic Acids Research. 2019. Vol. 47. P. 427-432. doi: 10.1093/nar/gky995


17. Enjalbert F., Rapior S., Nouguier-Soulé J. et al. Treatment of Amatoxin poisoning: 20-year retrospective analysis / J. Clin. Toxicol. 2002. Vol. 40, N 6. Р. 715-757. doi: 10.1081/clt-120014646.


18. Escudie L., Francoz C., Vinel J.-P. et al. Amanita phalloides poisoning: Reassessment of prognostic factors and indications for emergency liver transplantation / J. Hepatol. 2007. Vol. 46, N 3. Р. 466 - 473. doi: 10.1016/j.jhep.2006.10.013.


19. Faulstich H. New aspects of Amanita poisoning / Klin. Wochenschr. 1979. Vol. 57. P. 1143-1152. doi: 10.1007/BF01491754.


20. Faulstich H., Buehring H.J., Seitz J. Physical properties and function of phallolysin / Biochemistry. 1983. Vol. 22, N 19. Р. 4574-4580. doi: 10.1021/bi00288a035.


21. Faulstich H., Kirchner K., Derenzini M. Strongly enhanced toxicity of the mushroom toxin α-amanitin by an amatoxin-specific Fab or monoclonal antibody / Toxicon. 1988. Vol. 26. Р. 491-499. doi: 10.1016/0041-0101(88)90188-2.


22. Fiume L., Sperti S., Montanaro L. et al. Amanitins do not bind to serum albumin / Lancet. 1977. Vol. 309, N 8021. Р. 1111. doi:10.1016/s0140-6736(77)92372-8.


23. Ford W.W. The distribution of haemolysins, agglutinins, and poisons in fungi, espe-cially the Amanitas, the Entolomas, the Lactarius and the Inocybes / J. Pharmacol. Exp. Ther. 1911. Vol. 2. P. 285-318.


24. Frangež, R., Šuput, D., Molgó, J. et al. Ostreolysin A/Pleurotolysin B and equinatox-ins: structure, function and pathophysiological effects of these pore-forming proteins / Toxins (Basel). 2017. Vol. 9, N 4. Р. 128. doi: 10.3390/toxins9040128.


25. Garcia J., Carvalho A.T.P., Dourado D.F. et al. New in silico insights into the inhibi-tion of RNAP II by α-amanitin and the protective effect mediated by effective antidotes / J. Mol. Graph. Modell. 2014. Vol. 51. P. 120-127. doi: 10.1016/j.jmgm.2014.05.002.


26. Garcia J., Costa V.M., Bovolini A. et al. An effective antidotal combination of poly-myxin B and methylprednisolone for α-amanitin intoxication / Arch. Toxicol. 2019. Vol. 93, N 5. P.1449-1463. doi: 10.1007/s00204-019-02426-5.


27. Garcia J., Costa V.M., Carvalho A. et al. Amanita phalloides poisoning: Mechanisms of toxicity and treatment / Food Chem. Toxicol. 2015. Vol. 86. P. 41-55. doi: 10.1016/j.fct.2015.09.008.


28. Garner C.D., Armstrong E.M., Berry R.E. et al. Investigations of Amavadin / J. Inorg. Biochem. 2000. Vol. 80, N 1-2. Р. 17-20. doi:10.1016/s0162-0134(00)00034-9.


29. Govorushko S., Rezaee R., Dumanov J. et al. Poisoning associated with the use of mushrooms: A review of the global pattern and main characteristics / Food and Chem. Tox. 2019. Vol. 128. Р. 267-279. doi: 10.1016/j.fct.2019.04.016.


30. Graeme K.A. Mycetism: a review of the recent literature / J. Med. Tox. 2014. Vol. 10, N2. Р. 173-189. doi: 10.1007/s13181-013-0355-2.


31. Gulden G., Dunham S., Stockman J. DNA studies in the Galerina marginata complex / Mycol. Res. 2001. Vol. 105. P. 432- 440. doi: 10.1017/S0953756201003707.


32. Gummin D.D., Mowry J.B., Spyker D.A. et al. Annual report of the Аmerican associa-tion of poison control centers' national poison data system (NPDS): 35th Annual Report. Ph.: Clin. Toxicol., 2018. 203 p.


33. He Z., Su Y., Li S. et al. Development and evaluation of isothermal amplification methods for rapid detection of lethal Amanita species / Front. Microbiol. 2019. Vol. 10. P. 15-23. doi: 10.3389/fmicb.2019.01523.


34. Igaz L.M., Vianna M.R., Medina J.H. et al. Two time periods of hippocampal mRNA synthesis are required for memory consolidation of fear-motivated learning / J. Neurosci. 2002. Vol. 22, N 15. Р. 6781-6789. doi: 10.1523/JNEUROSCI.22-15-06781.2002.


35. Jaeger A., Jehl F., Flesch F. et al. Kinetics of amatoxins in human poisoning: Thera-peutic implications / J. Toxicol.: Clin. Toxicol. 1993. Vol. 31, N 1. Р. 63-80. doi: 10.3109/15563659309000374.


36. Juntes P., Rebolj K., Sepčić K. et al. Ostreolysin induces sustained contraction of por-cine coronary arteries and endothelial dysfunction in middle- and large-sized vessels. / Toxi-con. 2009. Vol. 54, N 6. P. 784-792. doi: 10.1016/j.toxicon.2009.06.005.


37. Kaplan C.D., Larsson K.-M., Kornberg R.D. The RNA Polymerase II Trigger Loop functions in substrate selection and is directly targeted by α-Amanitin / Mol. Cell. 2008. Vol. 3, N 5. Р. 547-556. doi: 10.1016/j.molcel.2008.04.023.


38. Kaya E., Surmen M.G., Yaykasli K.O. et al. Dermal absorption and toxicity of alpha amanitin in mice / Cutan. Ocul. Toxicol. 2014. Vol. 33, N 2. Р. 154-160. doi: 10.3109/15569527.2013.802697.


39. Kieslichova E., Frankova S., Protus M. et al. Acute liver failure due to Amanita phal-loides poisoning: Therapeutic approach and outcome / Transplant. Proc. 2018. Vol. 50, N 1. Р. 192-197. doi: 10.1016/j.transproceed.2017.11.032.


40. Kim Y.C., Kim E.J., Lee E.D. et al. Comparative bioavailability of silibinin in healthy male volunteers. 2003. Vol. 41. P. 593-596. doi: 10.5414/CPP41593.


41. Krasnodębski M., Grąt M., Hołówko W. et al. Results of liver transplantation in pa-tients with acute liver failure due to Amanita phalloides and paracetamol (acetaminophen) in-toxication / Gastroenterol. Rev. 2016. Vol. 2. P. 90-95. doi: 10.5114/pg.2015.52031.


42. Lacombe G., St-Onge M. Silibinin in suspected amatoxin-containing mushroom poi-soning / Emerg. Med. J. 2015. Vol. 33, N 1. Р. 76-77. doi: 10.1136/emermed-2015-205558.1.


43. Letschert K., Faulstich H., Keller D. et al. Molecular characterization and inhibition of amanitin uptake into human hepatocytes / Toxicol. Sci. 2006. Vol. 91, N 1. P. 140-149. doi: 10.1093/toxsci/kfj141.


44. Li L., Lee T. K., Meier P. J., Ballatori N. Identification of glutathione as a driving force and leukotriene substrate for OATP1, the hepatic sinusoidal organic solute transporter / J. Biol. Chem. 1998. Vol. 273, N26. Р. 16184-16191. doi: 10.1074/jbc.273.26.16184.


45. Loranger A. Toxicity of peptides of Amanita virosa mushrooms in mice / Fund. Appl. Toxicol. 1985. Vol. 5, N 6. Р. 1144-1152. doi: 10.1016/0272-0590(85)90151-4.


46. Lu H., Choudhuri S., Ogura K. et al. Characterization of Organic Anion Transporting Polypeptide 1b2-null mice: Essential role in hepatic uptake/toxicity of Phalloidin and Micro-cystin-LR / Toxicol. Sci. 2008. Vol. 103, N 1. Р. 35-45. doi: 10.1093/toxsci/kfn038.


47. Madhok M., Scalzo A.J., Blume C.M. et al. Amanita bisporigera ingestion: mistaken identity, dose-related toxicity, and improvement despite severe hepatotoxicity / Pediatr. Emerg. Care. 2006. Vol. 22. P. 177-80. doi: 10.1097/01.pec.0000202459.49731.33.


48. Magdalan J., Ostrowska A., Piotrowska A. et al. Failure of Benzylpenicillin, N-acetylcysteine and Silibinin to reduce α-amanitin hepatotoxicity / In Vivo. 2009. Vol. 23, N 3. Р. 393-399.


49. Mahagita C., Grassl S. M., Piyachaturawat P. et al. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport / Am. J. Physiol.: Gastr. Liv. Physiol. 2007. Vol. 293, N 1. Р. 271-278. doi: 10.1152/ajpgi.00075.2007.


50. Manautou J.E., Campion S.N., Aleksunes L.M. Regulation of hepatobiliary transport-ers during liver injury / Comprehensive Toxicology. 2010. Vol. 9. P. 175-220. doi: 10.1016/b978-0-08-046884-6.01008-3.


51. Monhart V., Balíkovа M., Tlustаkovа M. The sorption effectiveness of Czech-manufactured hemoperfusion sorbents for amatoxins / Cas. Lek. Cesk. 1994. Vol. 133, N 6. Р. 181-183.


52. Montanaro N., Novello F., Stirpe F. Effect of alpha-amanitin on ribonucleic acid pol-ymerase II of rat brain nuclei and on retention of avoidance conditioning / Biochem. J. 1971. Vol. 125, N 4. P. 1087-1090. doi: 10.1042/bj1251087.


53. Nakanishi T., Tamai I. Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs / Drug Metabol. Pharmac. 2012. Vol. 27. N 1. Р. 106-121. doi: 10.2133/dmpk.dmpk-11-rv-099.


54. Nguyen V. In vivo degradation of RNA polymerase II largest subunit triggered by al-pha-amanitin / Nucl. Ac. Res. 1996. Vol. 24, N 15. Р. 2924-2929. doi: 10.1093/nar/24.15.2924.


55. Piqueras J., Duran-Suarez J., Massuet L., Hernandez-Sanchez J. Mushroom poison-ing: therapeutic apheresis or forced diuresis / Transfus. 1987. Vol. 27, N 1. Р. 116-117. doi: 10.1046/j.1537-2995.1987.27187121459.x.


56. Powell J., Farasyn T., Kock K. et al. Novel mechanism of impaired function of organic anion-transporting polypeptide 1B3 in human hepatocytes: Post-translational regulation of OATP1B3 by protein kinase C activation / Drug Metabol. Disposit. 2014. Vol. 42, N 11. Р. 1964-1970. doi: 10.1124/dmd.114.056945.


57. Satlin L.M., Amin V., Wolkoff A.W. Organic anion transporting polypeptide mediates organic anion/HCO3− exchange / J. Biol. Chem. 1997. Vol 272, N 42. Р. 26340-26345. doi: 10.1074/jbc.272.42.26340.


58. Sawicki S.G., Godman G.C. On the differential cytotoxicity of actinomycin D / J. Cell Biol. 1971. Vol. 50, N 3. Р. 746-761. doi: 10.1083%2Fjcb.50.3.746.


59. Seeger R., Bunsen E. Degranulation of rat mast cells in vitro by the fungal cytolysins phallolysin, rubescenslysin and fascicularelysin / Naunyn-Schmiedeberg?s Arch. of Pharm. 1980. Vol. 315, N 2. Р. 163-166. doi: 10.1007/bf00499259.


60. Stasyk T., Lutsik-Kordovsky M., Wernstedt C. et al. A new highly toxic protein iso-lated from the death cap Amanita phalloides is an l-amino acid oxidase / FEBS J. 2010. Vol. 277, N 5. Р. 1260-1269. doi: 10.1111/j.1742-4658.2010.07557.x.


61. Sun J., Zhang Y.T, Niu Y.M. et al. Effect of biliary drainage on the toxicity and toxi-cokinetics of Amanita exitialis in Beagles / Toxins (Basel). 2018. Vol. 10, N 6. Р. 21-25. doi: 10.3390/toxins10060215.


62. Sun J., Zhang, H.-S., Li H.-J. et al. A case study of Lepiota brunneoincarnata poison-ing with endoscopic nasobiliary drainage in Shandong, China / Toxicon. 2019. Vol. 161. P. 12-16. doi: 10.1016/j.toxicon.2019.02.017.


63. Takada Y., Ishiguro S., Fukunaga K. Large-animal models of fulminant hepatic failure / J. Artific. Organs. 2003. Vol. 6, N 1. Р. 9-13. doi: 10.1007/s100470300001.


64. Tang S., Zhou Q., He Z. et al. Cyclopeptide toxins of lethal amanitas: Compositions, distribution and phylogenetic implication / Toxicon. 2016. Vol. 120. P. 78-88. doi:10.1016/j.toxicon.2016.07.018


65. Thiel C., Thiel K., Klingert W. et al. The enterohepatic circulation of amanitin: Kinet-ics and therapeutical implications / Toxicol. Letters. 2011. Vol. 203, N 2. Р. 142-146. doi: 10.1016/j.toxlet.2011.03.016.


66. Thomson M.M.S., Hines R.N., Schuetz E.G. et al. Expression patterns of organic ani-on transporting polypeptides 1B1 and 1B3 protein in human pediatric liver / Drug Metabol. Disposit. 2016. Vol. 44, N 7. Р. 999-1004. doi: 10.1124/dmd.115.069252.


67. Walton J. Chemistry of the Amanita peptide toxins. In: The Cyclic peptide toxins of Amanita and other poisonous mushrooms. Ed. J. Walton. Springer: Cham, 2018. P. 19-57. doi: 10.1007/978-3-319-76822-9_2.


68. White J., Weinstein S.A., De Haro L. et al. Mushroom poisoning: A proposed new clinical classification / Toxicon. 2019. Vol. 157. Р. 53-65. doi: 10.1016/j.toxicon.2018.11.007.


69. Wieland T. The toxic peptides from Amanita mushrooms / Int. J. Pept. Prot. Res. 1983 Vol. 22, N 3. Р. 257-276. doi: 10.1111/j.1399-3011.1983.tb02093.x.


70. Ye Y., Liu Z. Management of Amanita phalloides poisoning: A literature review and update / J. Crit. Care. 2018. V 46. Р. 17-22. doi: 10.1016/j.jcrc.2018.03.028.


71. Yilmaz I., Ermis F., Akata I. et al. A case study: What doses of Amanita phalloides and Amatoxins are lethal to humans? / Wild. Environ. Med. 2015. Vol. 26, N 4. Р. 491-496. doi: 10.1016/j.wem.2015.08.002.


72. Yin X., Yang A., Jin-Ming G. Mushroom toxins: chemistry and toxicology / J. Agri-cult. Food Chem. 2019. Vol. 18, N 67. Р. 5053-5071. doi: 10.1021/acs.jafc.9b00414.


73. Zeng X., Guo F., Ouyang D. A review of the pharmacology and toxicology of aucubin / Fitoter. 2019. Vol. 140. 39 р. doi: 10.1016/j.fitote.2019.104443.


74. Zheleva A., Michelot D., Zhelev Z.D. Sensitivity of alpha-amanitin to oxidation by a lactoperoxidase-hydrogen peroxide system / Toxicon. 2000. Vol. 38, N 8. Р. 1055-1063. doi: 10.1016/s0041-0101(99)00217-2.


75. Zheleva A., Tolekova A., Zhelev M. Free radical reactions might contribute to severe alpha amanitin hepatotoxicity - A hypothesis / Med. Hypoth. 2007. Vol. 69, N 2. Р. 361-367. doi: 10.1016/j.mehy.2006.10.066.





References:


1. Vishnevskij M.V. Yаdovitye griby Rossii. M: Prospekt, 2019. 448 p. [In Russian].


2. Gurevich L.S., Zhurkovich I.K., Nezdojminogo E.L. Izuchenie toksinov Amanita ver-na (Bull.: Fr.) Vitt. i A. virosa (Bull.: Fr.) Vitt. metodom vysokoeffektivnoj zhidkostnoj hro-matografii / Mikologiya i fitopatologiya. 1995. T. 29, N 3. P. 32-39. [In Russian].


3. Zaraf'yanc G.N. Sudebno-medicinskaya diagnostika otravlenij nekotorymi yado-vitymi gribami pri letal'nom iskhode v stacionare / Sudebno-medicinskaya ekspertiza. 2016. N1. P. 22-28. doi: 10.17116/sudmed201659122-28. [In Russian].


4. Medicinskaya toksikologiya: Nacional'noe rukovodstvo. Ad.: E.A. Luzhnikov. M.: GEOTAR-Media, 2012. 928 p. [In Russian].


5. Musselius S.G., Ryk. A.A. Otravleniya gribami. M.: [b. i.], 2002. 310 p. [In Russian].


6. Nezdojminogo E.L. Semejstvo pautinnikovye. SPb.: Nauka, 1996. 408 p. (Opredelitel' gribov Rossii: Poryadok agarikovye; Is. 1).


7. Federal'nye klinicheskie rekomendacii. Toksicheskoe dejstvie drugih yadovityh vesh-chestv, soderzhashchihsya v syedennyh gribah / Ad. Y.N. Ostapenko. - M.: Associaciya klinicheskih toksikologov, 2014. - 37 s. - Elektronnyj resurs // Russkoyazychnoe toksiko-logicheskoe obshchestvo [Website]. - 2020. - URL: http://www.toxrus.ru/node/49. (Date ac-cess: 10.03.2020). [In Russian].


8. Sokolov A.V., Il'in I.B., Nastaeva M.V. et al. Povrezhdenie serdca pri ostrom otrav-lenii amatoksinom: elektrokardiograficheskie i morfologicheskie sostavlyayushchie / Tezisy VI Evrazijskogo kongressa kardiologov. 2018. Р. 47. [In Russian].


9. Shilov V.V., Martinson T.G., Lukin V.A. Ostrye otravleniya yadovitymi gribami: posobie dlya vrachej. SPb.: izdanie Politekh. In-ta, 2010. 23 p. [In Russian].


10. Avedissian S.N., Liu J., Rhodes N.J. et al. A review of the clinical pharmacokinetics of Polymyxin B / Antibiot. (Basel). 2019. Vol. 8, N 1. 12 r. doi: 10.3390/antibiotics8010031


11. Beuhler M.C. Overview of mushroom poisoning / Crit. Care Toxicol. 2016. P. 1-26. doi: 10.1007/978-3-319-20790-2_120-1.


12. Boyer J.C., Hernandez F., Estorc J. et al. Management of maternal Amanita phal-loides poisoning during the first trimester of pregnancy: a case report and review of the litera-ture / Clin. Chem. 2001. Vol. 47. P. 971-974. doi: 10.1093/clinchem/47.5.971.


13. Brandenburg W.E., Ward K.J. Mushroom poisoning epidemiology in the United States / Mycologia. 2018. Vol. 110, N 4. R. 637-641. doi: 10.1080/00275514.2018.1479561.


14. Chang I.M. Liver-protective activities of aucubin derived from traditional oriental medi-cine / Res. Commun. Mol. Pathol. Pharmacol. 1998. Vol. 102, 2. R. 189-204.


15. Derheimer F. A., O?Hagan H. M., Krueger H. M. et al. RPA and ATR link transcrip-tional stress to p53 / Proceed. Nation. Acad. Sci. 2007. Vol. 104, 31. R. 12778-12783. doi: 10.1073/pnas.0705317104.


16. El-Gebali S., Mistry J., Bateman A. et al. The Pfam protein families database in 2019 / Nucleic Acids Research. 2019. Vol. 47. P. 427-432. doi: 10.1093/nar/gky995


17. Enjalbert F., Rapior S., Nouguier-Soulé J. et al. Treatment of Amatoxin poisoning: 20-year retrospective analysis / J. Clin. Toxicol. 2002. Vol. 40, 6. R. 715-757. doi: 10.1081/clt-120014646.


18. Escudie L., Francoz C., Vinel J.-P. et al. Amanita phalloides poisoning: Reassessment of prognostic factors and indications for emergency liver transplantation / J. Hepatol. 2007. Vol. 46, 3. R. 466 - 473. doi: 10.1016/j.jhep.2006.10.013.


19. Faulstich H. New aspects of Amanita poisoning / Klin. Wochenschr. 1979. Vol. 57. P. 1143-1152. doi: 10.1007/BF01491754.


20. Faulstich H., Buehring H.J., Seitz J. Physical properties and function of phallolysin / Bio-chemistry. 1983. Vol. 22, ? 19. R. 4574-4580. doi: 10.1021/bi00288a035.


21. Faulstich H., Kirchner K., Derenzini M. Strongly enhanced toxicity of the mushroom toxin α-amanitin by an amatoxin-specific Fab or monoclonal antibody / Toxicon. 1988. Vol. 26. R. 491-499. doi: 10.1016/0041-0101(88)90188-2.


22. Fiume L., Sperti S., Montanaro L. et al. Amanitins do not bind to serum albumin / Lancet. 1977. Vol. 309, 8021. R. 1111. doi:10.1016/s0140-6736(77)92372-8.


23. Ford W.W. The distribution of haemolysins, agglutinins, and poisons in fungi, espe-cially the Amanitas, the Entolomas, the Lactarius and the Inocybes / J. Pharmacol. Exp. Ther. 1911. Vol. 2. P. 285-318.


24. Frangež, R., Šuput, D., Molgó, J. et al. Ostreolysin A/Pleurotolysin B and equinatox-ins: structure, function and pathophysiological effects of these pore-forming proteins / Toxins (Ba-sel). 2017. Vol. 9, 4. R. 128. doi: 10.3390/toxins9040128.


25. Garcia J., Carvalho A.T.P., Dourado D.F. et al. New in silico insights into the inhibi-tion of RNAP II by α-amanitin and the protective effect mediated by effective antidotes / J. Mol. Graph. Modell. 2014. Vol. 51. P. 120-127. doi: 10.1016/j.jmgm.2014.05.002.


26. Garcia J., Costa V.M., Bovolini A. et al. An effective antidotal combination of poly-myx-in B and methylprednisolone for α-amanitin intoxication / Arch. Toxicol. 2019. Vol. 93, 5. P.1449-1463. doi: 10.1007/s00204-019-02426-5.


27. Garcia J., Costa V.M., Carvalho A. et al. Amanita phalloides poisoning: Mechanisms of toxicity and treatment / Food Chem. Toxicol. 2015. Vol. 86. P. 41-55. doi: 10.1016/j.fct.2015.09.008.


28. Garner C.D., Armstrong E.M., Berry R.E. et al. Investigations of Amavadin / J. Inorg. Biochem. 2000. Vol. 80, 1-2. R. 17-20. doi:10.1016/s0162-0134(00)00034-9.


29. Govorushko S., Rezaee R., Dumanov J. et al. Poisoning associated with the use of mush-rooms: A review of the global pattern and main characteristics / Food and Chem. Tox. 2019. Vol. 128. R. 267-279. doi: 10.1016/j.fct.2019.04.016.


30. Graeme K.A. Mycetism: a review of the recent literature / J. Med. Tox. 2014. Vol. 10, ?2. R. 173-189. doi: 10.1007/s13181-013-0355-2.


31. Gulden G., Dunham S., Stockman J. DNA studies in the Galerina marginata complex / Mycol. Res. 2001. Vol. 105. P. 432- 440. doi: 10.1017/S0953756201003707.


32. Gummin D.D., Mowry J.B., Spyker D.A. et al. Annual report of the American associa-tion of poison control centers' national poison data system (NPDS): 35th Annual Report. Ph.: Clin. Toxicol., 2018. 203 p.


33. He Z., Su Y., Li S. et al. Development and evaluation of isothermal amplification meth-ods for rapid detection of lethal Amanita species / Front. Microbiol. 2019. Vol. 10. P. 15-23. doi: 10.3389/fmicb.2019.01523.


34. Igaz L.M., Vianna M.R., Medina J.H. et al. Two time periods of hippocampal mRNA synthesis are required for memory consolidation of fear-motivated learning / J. Neurosci. 2002. Vol. 22, 15. R. 6781-6789. doi: 10.1523/JNEUROSCI.22-15-06781.2002.


35. Jaeger A., Jehl F., Flesch F. et al. Kinetics of amatoxins in human poisoning: Thera-peutic implications / J. Toxicol.: Clin. Toxicol. 1993. Vol. 31, 1. R. 63-80. doi: 10.3109/15563659309000374.


36. Juntes P., Rebolj K., Sepčić K. et al. Ostreolysin induces sustained contraction of por-cine coronary arteries and endothelial dysfunction in middle- and large-sized vessels. / Toxi-con. 2009. Vol. 54, 6. P. 784-792. doi: 10.1016/j.toxicon.2009.06.005.


37. Kaplan C.D., Larsson K.-M., Kornberg R.D. The RNA Polymerase II Trigger Loop func-tions in substrate selection and is directly targeted by α-Amanitin / Mol. Cell. 2008. Vol. 3, N 5. R. 547-556. doi: 10.1016/j.molcel.2008.04.023.


38. Kaya E., Surmen M.G., Yaykasli K.O. et al. Dermal absorption and toxicity of alpha am-anitin in mice / Cutan. Ocul. Toxicol. 2014. Vol. 33, N 2. R. 154-160. doi: 10.3109/15569527.2013.802697.


39. Kieslichova E., Frankova S., Protus M. et al. Acute liver failure due to Amanita phal-loides poisoning: Therapeutic approach and outcome / Transplant. Proc. 2018. Vol. 50, N 1. R. 192-197. doi: 10.1016/j.transproceed.2017.11.032.


40. Kim Y.C., Kim E.J., Lee E.D. et al. Comparative bioavailability of silibinin in healthy male volunteers. 2003. Vol. 41. P. 593-596. doi: 10.5414/CPP41593.


41. Krasnodębski M., Grąt M., Hołówko W. et al. Results of liver transplantation in pa-tients with acute liver failure due to Amanita phalloides and paracetamol (acetaminophen) in-toxication / Gastroenterol. Rev. 2016. Vol. 2. P. 90-95. doi: 10.5114/pg.2015.52031.


42. Lacombe G., St-Onge M. Silibinin in suspected amatoxin-containing mushroom poi-son-ing / Emerg. Med. J. 2015. Vol. 33, N 1. R. 76-77. doi: 10.1136/emermed-2015-205558.1.


43. Letschert K., Faulstich H., Keller D. et al. Molecular characterization and inhibition of amanitin uptake into human hepatocytes / Toxicol. Sci. 2006. Vol. 91, N 1. P. 140-149. doi: 10.1093/toxsci/kfj141.


44. Li L., Lee T. K., Meier P. J., Ballatori N. Identification of glutathione as a driving force and leukotriene substrate for OATP1, the hepatic sinusoidal organic solute transporter / J. Biol. Chem. 1998. Vol. 273, N26. R. 16184-16191. doi: 10.1074/jbc.273.26.16184.


45. Loranger A. Toxicity of peptides of Amanita virosa mushrooms in mice / Fund. Appl. Toxicol. 1985. Vol. 5, N 6. R. 1144-1152. doi: 10.1016/0272-0590(85)90151-4.


46. Lu H., Choudhuri S., Ogura K. et al. Characterization of Organic Anion Transporting Polypeptide 1b2-null mice: Essential role in hepatic uptake/toxicity of Phalloidin and Micro-cys-tin-LR / Toxicol. Sci. 2008. Vol. 103, N 1. R. 35-45. doi: 10.1093/toxsci/kfn038.


47. Madhok M., Scalzo A.J., Blume C.M. et al. Amanita bisporigera ingestion: mistaken iden-tity, dose-related toxicity, and improvement despite severe hepatotoxicity / Pediatr. Emerg. Care. 2006. Vol. 22. P. 177-80. doi: 10.1097/01.pec.0000202459.49731.33.


48. Magdalan J., Ostrowska A., Piotrowska A. et al. Failure of Benzylpenicillin, N-acetylcysteine and Silibinin to reduce α-amanitin hepatotoxicity / In Vivo. 2009. Vol. 23, N 3. R. 393-399.


49. Mahagita C., Grassl S. M., Piyachaturawat P. et al. Human organic anion transporter 1B1 and 1B3 function as bidirectional carriers and do not mediate GSH-bile acid cotransport / Am. J. Physiol.: Gastr. Liv. Physiol. 2007. Vol. 293, N 1. R. 271-278. doi: 10.1152/ajpgi.00075.2007.


50. Manautou J.E., Campion S.N., Aleksunes L.M. Regulation of hepatobiliary transport-ers during liver injury / Comprehensive Toxicology. 2010. Vol. 9. P. 175-220. doi: 10.1016/b978-0-08-046884-6.01008-3.


51. Monhart V., Balíkova M., Tlustakova M. The sorption effectiveness of Czech-manufactured hemoperfusion sorbents for amatoxins / Cas. Lek. Cesk. 1994. Vol. 133, N 6. R. 181-183.


52. Montanaro N., Novello F., Stirpe F. Effect of alpha-amanitin on ribonucleic acid poly-merase II of rat brain nuclei and on retention of avoidance conditioning / Biochem. J. 1971. Vol. 125, N 4. P. 1087-1090. doi: 10.1042/bj1251087.


53. Nakanishi T., Tamai I. Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs / Drug Metabol. Pharmac. 2012. Vol. 27. N 1. R. 106-121. doi: 10.2133/dmpk.dmpk-11-rv-099.


54. Nguyen V. In vivo degradation of RNA polymerase II largest subunit triggered by al-pha-amanitin / Nucl. Ac. Res. 1996. Vol. 24, N 15. R. 2924-2929. doi: 10.1093/nar/24.15.2924.


55. Piqueras J., Duran-Suarez J., Massuet L., Hernandez-Sanchez J. Mushroom poison-ing: therapeutic apheresis or forced diuresis / Transfus. 1987. Vol. 27, N 1. R. 116-117. doi: 10.1046/j.1537-2995.1987.27187121459.x.


56. Powell J., Farasyn T., Kock K. et al. Novel mechanism of impaired function of organic anion-transporting polypeptide 1B3 in human hepatocytes: Post-translational regulation of OATP1B3 by protein kinase C activation / Drug Metabol. Disposit. 2014. Vol. 42, N 11. R. 1964-1970. doi: 10.1124/dmd.114.056945.


57. Satlin L.M., Amin V., Wolkoff A.W. Organic anion transporting polypeptide mediates organic anion/HCO3− exchange / J. Biol. Chem. 1997. Vol 272, N 42. R. 26340-26345. doi: 10.1074/jbc.272.42.26340.


58. Sawicki S.G., Godman G.C. On the differential cytotoxicity of actinomycin D / J. Cell Biol. 1971. Vol. 50, N 3. R. 746-761. doi: 10.1083%2Fjcb.50.3.746.


59. Seeger R., Bunsen E. Degranulation of rat mast cells in vitro by the fungal cytolysins phallolysin, rubescenslysin and fascicularelysin / Naunyn-Schmiedebergs Arch. of Pharm. 1980. Vol. 315, N 2. R. 163-166. doi: 10.1007/bf00499259.


60. Stasyk T., Lutsik-Kordovsky M., Wernstedt C. et al. A new highly toxic protein iso-lated from the death cap Amanita phalloides is an l-amino acid oxidase / FEBS J. 2010. Vol. 277, N 5. R. 1260-1269. doi: 10.1111/j.1742-4658.2010.07557.x.


61. Sun J., Zhang Y.T, Niu Y.M. et al. Effect of biliary drainage on the toxicity and toxi-coki-netics of Amanita exitialis in Beagles / Toxins (Basel). 2018. Vol. 10, N 6. R. 21-25. doi: 10.3390/toxins10060215.


62. Sun J., Zhang, H.-S., Li H.-J. et al. A case study of Lepiota brunneoincarnata poison-ing with endoscopic nasobiliary drainage in Shandong, China / Toxicon. 2019. Vol. 161. P. 12-16. doi: 10.1016/j.toxicon.2019.02.017.


63. Takada Y., Ishiguro S., Fukunaga K. Large-animal models of fulminant hepatic failure / J. Artific. Organs. 2003. Vol. 6, N 1. R. 9-13. doi: 10.1007/s100470300001.


64. Tang S., Zhou Q., He Z. et al. Cyclopeptide toxins of lethal amanitas: Compositions, dis-tribution and phylogenetic implication / Toxicon. 2016. Vol. 120. P. 78-88. doi:10.1016/j.toxicon.2016.07.018


65. Thiel C., Thiel K., Klingert W. et al. The enterohepatic circulation of amanitin: Kinet-ics and therapeutical implications / Toxicol. Letters. 2011. Vol. 203, N 2. R. 142-146. doi: 10.1016/j.toxlet.2011.03.016.


66. Thomson M.M.S., Hines R.N., Schuetz E.G. et al. Expression patterns of organic ani-on transporting polypeptides 1B1 and 1B3 protein in human pediatric liver / Drug Metabol. Disposit. 2016. Vol. 44, N 7. R. 999-1004. doi: 10.1124/dmd.115.069252.


67. Walton J. Chemistry of the Amanita peptide toxins. In: The Cyclic peptide toxins of Am-anita and other poisonous mushrooms. Ed. J. Walton. Springer: Cham, 2018. P. 19-57. doi: 10.1007/978-3-319-76822-9_2.


68. White J., Weinstein S.A., De Haro L. et al. Mushroom poisoning: A proposed new clinical classification / Toxicon. 2019. Vol. 157. R. 53-65. doi: 10.1016/j.toxicon.2018.11.007.


69. Wieland T. The toxic peptides from Amanita mushrooms / Int. J. Pept. Prot. Res. 1983 Vol. 22, N 3. R. 257-276. doi: 10.1111/j.1399-3011.1983.tb02093.x.


70. Ye Y., Liu Z. Management of Amanita phalloides poisoning: A literature review and up-date / J. Crit. Care. 2018. V 46. R. 17-22. doi: 10.1016/j.jcrc.2018.03.028.


71. Yilmaz I., Ermis F., Akata I. et al. A case study: What doses of Amanita phalloides and Amatoxins are lethal to humans? / Wild. Environ. Med. 2015. Vol. 26, N 4. R. 491-496. doi: 10.1016/j.wem.2015.08.002.


72. Yin X., Yang A., Jin-Ming G. Mushroom toxins: chemistry and toxicology / J. Agri-cult. Food Chem. 2019. Vol. 18, N 67. R. 5053-5071. doi: 10.1021/acs.jafc.9b00414.


73. Zeng X., Guo F., Ouyang D. A review of the pharmacology and toxicology of aucubin / Fitoter. 2019. Vol. 140. 39 r. doi: 10.1016/j.fitote.2019.104443.


74. Zheleva A., Michelot D., Zhelev Z.D. Sensitivity of alpha-amanitin to oxidation by a lac-toperoxidase-hydrogen peroxide system / Toxicon. 2000. Vol. 38, N 8. R. 1055-1063. doi: 10.1016/s0041-0101(99)00217-2.


75. Zheleva A., Tolekova A., Zhelev M. Free radical reactions might contribute to severe al-pha amanitin hepatotoxicity - A hypothesis / Med. Hypoth. 2007. Vol. 69, N 2. R. 361-367. doi: 10.1016/j.mehy.2006.10.066.